These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 2978968)

  • 21. Plasma levels of atrial natriuretic peptide in man in primary aldosteronism, in Gordon's syndrome and in Bartter's syndrome.
    Tunny TJ; Higgins BA; Gordon RD
    Clin Exp Pharmacol Physiol; 1986 Apr; 13(4):341-5. PubMed ID: 2942327
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Arterial hypertension with hyperkalemia, tubular acidosis and normal renal function: Gordon syndrome and/or pseudohypoaldosteronism type II?].
    Ader JL; Waeber B; Suc JM; Brunner HR; Tran-Van T; Durand D; Praddaude F
    Arch Mal Coeur Vaiss; 1988 Jun; 81 Spec No():193-7. PubMed ID: 2973296
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Gordon's syndrome: a case report.
    Bruno CM; Sciacca C; Di Prima P; Castelli Z; Neri S
    Clin Exp Hypertens; 2004 Aug; 26(6):461-4. PubMed ID: 15554449
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Unusual association of hyperkalemia and hypertension.
    Soppi E; Viikari J; Seppälä P; Lehtonen A; Saarinen R; Miilunpalo S
    Hypertension; 1986 Feb; 8(2):174-7. PubMed ID: 2417952
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Endocrine sodium and volume regulation in familial hyperkalemia with hypertension.
    Isenring P; Lebel M; Grose JH
    Hypertension; 1992 Apr; 19(4):371-7. PubMed ID: 1532566
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Renal tubular sensitivity to atrial natriuretic factor in essential hypertension.
    Janssen WM; de Zeeuw D; van der Hem GK; de Jong PE
    J Hypertens; 1994 Apr; 12(4):439-47. PubMed ID: 8064168
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Multilocus linkage of familial hyperkalaemia and hypertension, pseudohypoaldosteronism type II, to chromosomes 1q31-42 and 17p11-q21.
    Mansfield TA; Simon DB; Farfel Z; Bia M; Tucci JR; Lebel M; Gutkin M; Vialettes B; Christofilis MA; Kauppinen-Makelin R; Mayan H; Risch N; Lifton RP
    Nat Genet; 1997 Jun; 16(2):202-5. PubMed ID: 9171836
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The syndrome of hypertension and hyperkalaemia without renal failure: long term correction by thiazide diuretic.
    Gordon RD; Hodsman GP
    Scott Med J; 1986 Jan; 31(1):43-4. PubMed ID: 3961473
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Glomerular hyperfiltration in essential hypertension: hormonal aspects.
    Regolisti G; Buzio C; Cavatorta A; De Martin L; Cavalli R; Perazzoli F; Coghi P; Cabassi A; Pucci F; Borghetti A
    Acta Biomed Ateneo Parmense; 1992; 63(1-2):163-73. PubMed ID: 1340661
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pseudohypoaldosteronism type II: proximal renal tubular acidosis and dDAVP-sensitive renal hyperkalemia.
    Nahum H; Paillard M; Prigent A; Leviel F; Bichara M; Gardin JP; Idatte JM
    Am J Nephrol; 1986; 6(4):253-62. PubMed ID: 3777034
    [TBL] [Abstract][Full Text] [Related]  

  • 31. George E. Brown memorial lecture. Role of atrial peptides in body fluid homeostasis.
    Ballermann BJ; Brenner BM
    Circ Res; 1986 May; 58(5):619-30. PubMed ID: 3011307
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Renal sites of action of physiological increases in plasma atrial natriuretic factor concentration in essential hypertension.
    Bruun NE; Skøtt P; Giese J
    J Hypertens; 1992 Jan; 10(1):37-47. PubMed ID: 1312549
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Atrial natriuretic factor (ANF) increases urinary protein excretion in patients with essential hypertension: a possible role of ANF for renal handling of protein.
    Suenaga K; Mizuno K; Niimura S; Mori K; Sato M; Tani M; Yabe R; Yatabe Y; Fukuchi S
    Biochem Biophys Res Commun; 1989 Feb; 158(3):936-42. PubMed ID: 2522002
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Reduced natriuretic effect of atrial natriuretic peptide in nephrotic syndrome: a possible role of decreased cyclic guanosine monophosphate.
    Jespersen B; Eiskjaer H; Mogensen CE; Sørensen SS; Pedersen EB
    Nephron; 1995; 71(1):44-53. PubMed ID: 8538848
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Atrial natriuretic factor influences renal diurnal rhythm in essential hypertension.
    Janssen WM; de Zeeuw D; van der Hem GK; de Jong PE
    Hypertension; 1992 Jul; 20(1):80-4. PubMed ID: 1535613
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Differential effects of atrial natriuretic peptide and dopamine on urinary protein excretion in chronic glomerulonephritis.
    Hirata Y; Ishii M; Fukui K; Hayakawa H; Suzuki E; Sugimoto T; Kimura K; Matsuoka H; Sugimoto T
    Clin Sci (Lond); 1991 Feb; 80(2):131-6. PubMed ID: 1848164
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The renal action of atrial natriuretic peptide during control of glomerular filtration.
    Burnett JC; Opgenorth TJ; Granger JP
    Kidney Int; 1986 Jul; 30(1):16-9. PubMed ID: 2943930
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A case report of Gordon's syndrome in a 20-year-old male with free medical family history.
    Kostakis ID; Tsoukalas NG; Aravantinos DC; Gkizis IG; Cholidou KG; Papadopoulos DP
    Hellenic J Cardiol; 2013; 54(1):64-8. PubMed ID: 23340132
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Atrial natriuretic peptide and the kidney.
    Ballermann BJ; Brenner BM
    Am J Kidney Dis; 1987 Jul; 10(1 Suppl 1):7-12. PubMed ID: 3037892
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Atrial natriuretic hormones--thirty years after the discovery of atrial volume receptors.
    Kramer HJ; Lichardus B
    Klin Wochenschr; 1986 Aug; 64(16):719-31. PubMed ID: 2945041
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.